SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QIAGEN (QGENF) - Star of Germany's Biotechs

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: (no name provided) who wrote (26)7/7/1997 2:06:00 PM
From: (no name provided)   of 122
 
QGENF stock now up to $52. Company worth nearly a billion dollars.

Unbelievable. Trailing p/e 135. Forward p/e 100.

Price/sales nearly 20.

As of this morning, you can buy Qiagen for $900 million or

Agouron $1.1 billion

Gilead $775 million (with $300 million in cash)

Is this rational?

Oh yeah, AlexBrown downgraded QGENF last week.

Kafka666
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext